	US 12,484,585 B2
	Zinc molybdate having a triclinic crystal structure, as an antimicrobial agent
J. Peter Guggenbichler, Kössen in Tirol (AT)
Assigned to AMISTEC GMBH & CO. KG, Kössen in Tirol (AT)
Appl. No. 17/288,792
Filed by AMISTEC GMBH & CO. KG, Kössen in Tirol (AT)
PCT Filed Oct. 25, 2019, PCT No. PCT/EP2019/079301 § 371(c)(1), (2) Date Apr. 26, 2021, PCT Pub. No. WO2020/084155, PCT Pub. Date Apr. 30, 2020.
Claims priority of application No. 18202862 (EP), filed on Oct. 26, 2018.
Prior Publication US 2022/0007649 A1, Jan. 13, 2022
Int. Cl. A01N 59/16 (2006.01); A01N 25/08 (2006.01); A01N 25/12 (2006.01)

CPC A01N 59/16 (2013.01) [A01N 25/08 (2013.01); A01N 25/12 (2013.01)]

2 Claims

1. A method comprising, utilizing zinc molybdate (ZnMoO₄) as an antimicrobial agent, wherein the ZnMoO₄consists of particles having a triclinic crystal structure and an average grain size of 0.2 μm, wherein the ZnMoO₄is free of particles having a grain size smaller than 0.1 μm.